Aprea Therapeutics updates shareholders on clinical programs and 2026 outlook
Go back to Aprea Therapeutics updates shareholders on clinical programs and 2026 outlook| Aperture Health, Inc. (NASDAQ: APRE) | Delayed: 0.66 +0.02 (3.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.64 | 52 Week High | $0.08 | |||
| Open | $0.67 | 52 Week Low | $0.00 | |||
| Day High | $0.70 | P/E | N/A | |||
| Day Low | $0.66 | EPS | $0.00 | |||
| Volume | 24,183 | |||||
